Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04818593 · ClinicalTrials.gov registry record · NA
A Sibling Oocyte Study- Comparison of ZyMotTM Microfluidics Device to Density Gradient for Sperm Selection During ICSI
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT04818593 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 108 participants.
The verdict
NCT04818593, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate whether the percentage of good quality embryo formation following Intracytoplasmic Sperm Injection (ICSI) is improved with the use of ZyMot method of microfluidic sperm separation compared to density gradient.
Interventions
- OTHER Density Gradient Centrifugation
- DEVICE ZyMot Multi Sperm Separation Device (850 ul)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2021-06-18 |
| Est. Completion | 2021-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04818593
The ClinicalTrials.gov registry entry for NCT04818593 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Density Gradient Centrifugation is the first listed.
NCT04818593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04818593 about?
NCT04818593 is a clinical study titled "A Sibling Oocyte Study- Comparison of ZyMotTM Microfluidics Device to Density Gradient for Sperm Selection During ICSI". The primary objective of this study is to evaluate whether the percentage of good quality embryo formation following Intracytoplasmic Sperm Injection (ICSI) is improved with the use of ZyMot method of microfluidic sperm separation compared to density gradient.
What is the current status of trial NCT04818593?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2021-06-18. Estimated completion is 2021-11-29.
What interventions are being tested in trial NCT04818593?
The interventions under investigation include: Density Gradient Centrifugation (OTHER), ZyMot Multi Sperm Separation Device (850 ul) (DEVICE).
Who is sponsoring clinical trial NCT04818593?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.